A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine

被引：0
|
作者：
Kotoe Takayoshi
Kosuke Sagara
Keita Uchino
Hitoshi Kusaba
Naotaka Sakamoto
Atsushi Iguchi
Eishi Baba
机构：
[1] Clinical Research Institute,Department of Medical Oncology
[2] National Hospital Organization Kyushu Medical Center,Department of Medicine and Biosystemic Science
[3] Kyushu University Graduate School of Medical Sciences,Department of Urology
[4] National Hospital Organization Kyushu Medical Center,Department of Comprehensive Clinical Oncology
[5] Faculty of Medical Sciences,undefined
[6] Kyushu University,undefined
来源：
BMC Cancer | / 15卷
关键词：
ABCB1; Adverse event; Bile duct carcinoma; Gemcitabine; Plasma concentration; Renal cell carcinoma; Sunitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
    B Beuselinck
    A Karadimou
    D Lambrechts
    B Claes
    P Wolter
    G Couchy
    J Berkers
    R Paridaens
    P Schöffski
    A Méjean
    V Verkarre
    E Lerut
    A de la Taille
    J-M Tourani
    P Bigot
    C Linassier
    S Négrier
    J Berger
    J-J Patard
    J Zucman-Rossi
    S Oudard
    British Journal of Cancer, 2013, 108 : 887 - 900
  • [32] Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
    Yoshimura, Akihiro
    Nakata, Wataru
    Yamamichi, Gaku
    Tsujimura, Go
    Tsujimoto, Yuichi
    Nin, Mikio
    Tsujihata, Masao
    UROLOGY CASE REPORTS, 2020, 32
  • [33] Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
    Gu, Cheng-Yuan
    Wang, Jun-jie
    Zhang, Hai-Liang
    Shi, Guo-Hai
    Ye, Ding-Wei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] Outcome of Patients With Renal Cell Carcinoma Metastatic to the Brain Treated With Sunitinib Without Local Therapy
    Lim, Zita Dubauskas
    Mahajan, Anita
    Weinberg, Jeffrey
    Tannir, Nizar M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (03): : 258 - 260
  • [35] Metastatic Adrenocortical Carcinoma Treated with Sunitinib: A Case Report
    Lee, Jeong-Ok
    Lee, Keun-Wook
    Kim, Chung-Jong
    Kim, Yu Jung
    Lee, Hee Eun
    Kim, Haeryoung
    Kim, Jee Hyun
    Bang, Soo-Mee
    Kim, Jae-Sung
    Lee, Jong Seok
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (03) : 183 - 185
  • [36] Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma
    Thomas Gregory
    Olivier Mir
    Jacques Medioni
    Bernard Augereau
    Stéphane Oudard
    Medical Oncology, 2010, 27 : 446 - 448
  • [37] Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma
    Gregory, Thomas
    Mir, Olivier
    Medioni, Jacques
    Augereau, Bernard
    Oudard, Stephane
    MEDICAL ONCOLOGY, 2010, 27 (02) : 446 - 448
  • [38] Metastatic collecting duct carcinoma of the kidney responded to sunitinib
    Miyake, Hideaki
    Haraguchi, Takahiro
    Takenaka, Atsushi
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (02) : 153 - 155
  • [39] Sunitinib (SUTENT®) for the treatment of metastatic renal cell carcinoma
    Hutson, Thomas E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (11) : 1723 - 1731
  • [40] Experience with sunitinib in the treatment of metastatic renal cell carcinoma
    Schmidinger, Manuela
    Larkin, James
    Ravaud, Alain
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 253 - 265
12345